One time injection of nanoparticles to treat skin cancer
Yale News - 02-Feb-2021Nanoparticles with chemotherapy agent act longer, a potential alternative to cancer surgeries
Michael Girardi
Professor of dermatology, Vice chair, Director of T32 Research Fellowship Program
Michael Girardi is the professor of dermatology, director of Yale Medicine Dermatology’s ECP (Photopheresis) Immunotherapy Program. Dr. Girardi is the holder/filer of 4 biomedical patents on cancer diagnosis and treatment and co-founder of two Yale startup companies.
Visit website: https://www.yalemedicine.org/specialists/michael_girardi
See also: 
Yale University
- Private Ivy League research university in New Haven, Connecticut
Details last updated 05-Feb-2021
Michael Girardi News
